特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
941368

ヒト成長ホルモンの世界市場:用途別・投与経路別・流通チャネル別・地域別 - 市場分析、シェア、動向、規模、予測 (2020~2026年)

Human Growth Hormone Market, By Application, By Route of Administration, By Distribution Channel, and By Geography - Analysis, Size, Share, Trends, & Forecast from 2020-2026

出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 206 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
ヒト成長ホルモンの世界市場:用途別・投与経路別・流通チャネル別・地域別 - 市場分析、シェア、動向、規模、予測 (2020~2026年)
出版日: 2020年05月01日
発行: AnalystView Market Insights
ページ情報: 英文 206 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のヒト成長ホルモンの市場規模は、2019年には45億3000万米ドルに達し、更に2020~2026年にかけて8.1%のCAGRで成長する見通しです。市場成長の主な要因として、成長ホルモンの有効性に関連する関心増大や、下垂体機能不全・腎臓病などの慢性疾患の有病率の上昇、各国政府の支援体制などが挙げられます。

当レポートでは、世界のヒト成長ホルモン (hGh) 市場について分析し、市場の定義や基本構造、主な市場促進・抑制要因、業界の競争力・求心力、市場シェア構造、用途別・投与経路別・流通チャネル別・地域別の市場動向見通し (過去4年間・今後8年間分)、主要企業のプロファイルなどについて調査しております。

第1章 ヒト成長ホルモン市場の概要

第2章 エグゼクティブサマリー

第3章 ヒト成長ホルモン:主な市場動向

  • 市場促進要因
    • 市場促進要因の影響度の分析
  • 市場抑制要因
    • 市場抑制要因の影響度の分析
  • 市場機会
  • 将来の市場動向

第4章 ヒト成長ホルモン:産業研究

  • ポーターのファイブフォース分析
  • マーケティング戦略分析
  • 市場成長の見通し:マッピング
  • 規制体制の分析

第5章 ヒト成長ホルモン:市場環境

  • 市場シェア分析
  • 主な技術革新企業 (イノベーター)
  • 市場区分データ:主要メーカー別
    • 既存企業の分析
    • 新規企業の分析

第6章 ヒト成長ホルモン市場:用途別

  • 概要
    • 市場シェア分析:用途別 (2019年、2026年)
  • ターナー症候群
    • 概要
    • 市場の分析・予測、対前年比成長率 (金額ベース、2015~2026年)
  • 成長ホルモン欠乏症
    • 小児成長ホルモン欠乏症
    • 成人成長ホルモン欠乏症
  • 突発性小人症
  • 在胎不当過小児 (SGA)
  • プラダー・ウィリー症候群 (PWS)

第7章 ヒト成長ホルモン市場:投与経路 (RoA) 別

  • 概要
    • 市場シェア分析:投与経路別 (2019年、2026年)
  • 皮下注射
  • 経口投与
  • 筋肉内注射
  • 静脈内 (IV) 注射

第8章 ヒト成長ホルモン市場:流通チャネル別

  • 概要
    • 市場シェア分析:流通チャネル別 (2019年、2026年)
  • オンライン薬局
  • 小売薬局
  • 病院薬局
  • 専門薬局

第9章 ヒト成長ホルモン市場:地域別

  • イントロダクション
    • 市場シェア分析:地域別 (2019年、2026年)
  • 北米市場
    • 概要
    • 域内の主要メーカー
    • 市場規模とその予測:国別 (金額ベース、2015~2026年)
    • 市場規模とその予測:用途別 (金額ベース、2015~2026年)
    • 市場規模とその予測:投与経路別 (金額ベース、2015~2026年)
    • 市場規模とその予測:流通チャネル別 (金額ベース、2015~2026年)
    • 米国
    • カナダ
  • 欧州市場
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • その他の欧州諸国
  • アジア太平洋地域 (APAC) 市場
    • インド
    • 中国
    • 日本
    • 韓国
    • その他のアジア太平洋地域諸国
  • ラテンアメリカ市場
    • ブラジル
    • メキシコ
    • アルゼンチン
    • その他のラテンアメリカ諸国
  • 中東・アフリカ地域
    • サウジアラビア
    • アラブ首長国連邦 (UAE)

第10章 主要ベンダーの分析

  • Ipsen
    • 企業概況
    • 財務実績
    • 製品の相互比較
    • 戦略展開状況
  • Ferring B.V.
  • Novartis AG
  • Genetech, Inc.
  • Merck KGaA
  • Sandoz International GmbH
  • Eli Lily and Company
  • Pfizer, Inc.
  • Novo Nordisk A/S
  • Teva Pharmaceutical Limited
  • AnkeBio Limited

第11章 アナリストの全方位的分析

第12章 付録

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Human Growth Hormone market: ApplicationSnapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Human Growth Hormone market, by Application2015-2026 (USD Million)
  • TABLE Human Growth Hormone market: Route of Administration Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Human Growth Hormone market, by Route of Administration 2015-2026 (USD Million)
  • TABLE Human Growth Hormone market: Distribution Channel Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Human Growth Hormone market, by Distribution Channel 2015-2026 (USD Million)
  • TABLE Human Growth Hormone market: Regional snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Human Growth Hormone market, by Region 2015-2026 (USD Million)
  • TABLE North America Human Growth Hormone market, by Country, 2015-2026 (USD Million)
  • TABLE North America Human Growth Hormone market, by Application, 2015-2026 (USD Million)
  • TABLE North America Human Growth Hormone market, by Route of Administration, 2015-2026 (USD Million)
  • TABLE North America Human Growth Hormone market, by Distribution Channel, 2015-2026 (USD Million)
  • TABLE Europe Human Growth Hormone market, by Country, 2015-2026 (USD Million)
  • TABLE Europe Human Growth Hormone market, by Application, 2015-2026 (USD Million)
  • TABLE Europe Human Growth Hormone market, by Route of Administration, 2015-2026 (USD Million)
  • TABLE Europe Human Growth Hormone market, by Distribution Channel, 2015-2026 (USD Million)
  • TABLE Asia Pacific Human Growth Hormone market, by Country, 2015-2026 (USD Million)
  • TABLE Asia Pacific Human Growth Hormone market, by Application, 2015-2026 (USD Million)
  • TABLE Asia Pacific Human Growth Hormone market, by Route of Administration, 2015-2026 (USD Million)
  • TABLE Asia Pacific Human Growth Hormone market, by Distribution Channel, 2015-2026 (USD Million)
  • TABLE Latin America Human Growth Hormone market, by Country, 2015-2026 (USD Million)
  • TABLE Latin America Human Growth Hormone market, by Application, 2015-2026 (USD Million)
  • TABLE Latin America Human Growth Hormone market, by Route of Administration, 2015-2026 (USD Million)
  • TABLE Latin America Human Growth Hormone market, by Distribution Channel, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Human Growth Hormone market, by Country, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Human Growth Hormone market, by Application, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Human Growth Hormone market, by Route of Administration, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Human Growth Hormone market, by Distribution Channel, 2015-2026 (USD Million)

List of Figures

  • FIGURE Human Growth Hormone market segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE Competitive Landscape; Key company market share analysis, 2018
  • FIGURE Application segment market share analysis, 2019 & 2026
  • FIGURE Application segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Turner Syndrome market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Growth Hormone Deficiency market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Pediatric Growth Hormone Deficiency market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Adult Growth Hormone Deficiency market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Idiopathic Short Stature market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Small for Gestational Age market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Prader-Willi Syndrome market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Route of Administration segment market share analysis, 2019 & 2026
  • FIGURE Route of Administration segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Subcutaneous market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Oral market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Intramuscular market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Intravenous market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Distribution Channel segment market share analysis, 2019 & 2026
  • FIGURE Distribution Channel segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Online Pharmacy market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Retail Pharmacy market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Hospital Pharmacy market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Specialty Pharmacy market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Regional segment market share analysis, 2019 & 2026
  • FIGURE Regional segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE North America Human Growth Hormone market share and leading players, 2018
  • FIGURE Europe Human Growth Hormone market share and leading players, 2018
  • FIGURE Asia Pacific Human Growth Hormone market share and leading players, 2018
  • FIGURE Latin America Human Growth Hormone market share and leading players, 2018
  • FIGURE Middle East and Africa Human Growth Hormone market share and leading players, 2018
  • FIGURE North America market share analysis by country, 2018
  • FIGURE U.S. Human Growth Hormone market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Canada Human Growth Hormone market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Europe Human Growth Hormone market share analysis by country, 2018
  • FIGURE Germany Human Growth Hormone market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Spain Human Growth Hormone market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Italy Human Growth Hormone market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE UK Human Growth Hormone market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE France Human Growth Hormone market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of the Europe Human Growth Hormone market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Asia Pacific Human Growth Hormone market share analysis by country, 2018
  • FIGURE India Human Growth Hormone market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE China Human Growth Hormone market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Japan Human Growth Hormone market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE South Korea Human Growth Hormone market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Singapore Human Growth Hormone market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of APAC Human Growth Hormone market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin America Human Growth Hormone market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin America Human Growth Hormone market share analysis by country, 2018
  • FIGURE Brazil Human Growth Hormone market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Mexico Human Growth Hormone market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Argentina Human Growth Hormone market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of LATAM Human Growth Hormone market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Human Growth Hormone market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Human Growth Hormone market share analysis by country, 2018
  • FIGURE Saudi Arabia Human Growth Hormone market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE United Arab Emirates Human Growth Hormone market size, forecast and trend analysis, 2015 to 2026 (USD Million)
目次

REPORT HIGHLIGHT

The human growth hormone market was valued at USD 4.53 billion by 2019, growing with 8.1% CAGR during the forecast period, 2020-2026.

Human growth hormone (hGh) also called somatotropin is a proteohormone produced by the pituitary gland that regulates reproduction, cell regeneration & repair, metabolism, and cell growth spurring the overall development of humans. For normal growth of the human body, the growth hormone levels should be optimum that can be regulated by factors such as lower glucose levels, exercise, sleep, and reduced stress levels. These hormones help in controlling body composition, body fluids, muscle & bone growth, recovery from injury, and sugar & fat metabolism. The human growth hormone also helps to boost muscle performance and strength.

Market Dynamics

The growing awareness related to the effectiveness of growth hormones and the growing prevalence of serious chronic diseases such as pituitary dysfunctions, kidney diseases are the major factors driving the growth of the global human growth hormone market. According to the Centers for Diseases Control & Prevention (CDC), around 6,000 adults in the U.S. are diagnosed with growth hormone deficiency each year. The incidence of growth human deficiency in adults has been estimated to affect 1 in 100,000 people every year, whereas in children it's 2 cases per 100,000 annually. Furthermore, the surge in compliance for growth hormone (GH) formulations and the rising demand for cost-effective GH therapies are other factors boosting the market growth. Conversely, the high costs related to the human growth hormone therapies and the adverse effects associated with these therapies are expected to hinder the market growth in the coming future. On the contrary, the presence of strong pipeline, investments by major market players, rising government initiatives, and extensive R&D activities are predicted to create lucrative growth opportunities in the overall market during the period of forecast.

Application Takeaway

Based on the application, the global market for human growth hormone is categorized into turner syndrome, growth hormone deficiency, idiopathic short stature, small for gestational age, and prader-willi syndrome. The growth hormone deficiency is further sub-categorized into pediatric growth hormone deficiency and adult growth hormone deficiency. Among these, the growth hormone (GH) deficiency segment accounted for the majority of market share in 2019 and is anticipated to play a dominant role during the forecast period. This dominance is majorly attributed to growing awareness amongst individuals regarding early diagnosis and treatment of growth hormone deficiency. In addition, the rise in the number of R&D activities and the introduction of novel drugs in the hGh market are other factors propelling the segmental market growth.

On the other hand, the turner syndrome segment is estimated to hold the second-largest share in the market during the period of forecast owing to the growing initiatives by various private and public organizations to spread awareness regarding the early diagnosis and treatment of turner syndrome.

Route of Administration Takeaway

Based on the route of administration, the overall hGh market is categorized into subcutaneous, oral, intramuscular, and intravenous. Of these, the subcutaneous segment subjugated the global hGh market in 2019 and is expected to maintain its dominance in the projected timeframe by 2026. This is mainly because the growth hormones when administered subcutaneously have more bioavailability than the other routes of administration. On the other hand, the oral route of administration segment is anticipated to witness lucrative growth during the forecast period owing to technological advancements and increasing R&D activities regarding the novel introduction of drugs.

Distribution Channel Takeaway

Based on the distribution channel, the worldwide market for human growth hormone is categorized into online pharmacy, retail pharmacy, hospital pharmacy, and specialty pharmacy. Among these, the hospital pharmacy segment held the largest market share in 2019 and is anticipated to witness progressive growth during the forecast period. This is mainly owing to increasing visits to hospitals coupled with growing awareness regarding growth hormone deficiency amongst individuals and its treatment. On the other hand, the online pharmacy segment is anticipated to grow at a significant rate in the projected timeframe owing to the high penetration of pharmacies mainly in developed regions of Europe and North America.

REGIONAL TAKEAWAY

Regionally, the global industry is divided into North America, Europe, Latin America, Asia Pacific, and the Middle East & Africa. The North America region registered for the majority of shares in the market in 2019 and is estimated to dominate the industry during the forecast period. This dominance is majorly attributed to favorable reimbursement scenario, increasing healthcare awareness, well-established healthcare infrastructure, and significant government initiatives. In addition, the presence of major market players in the region and increased access to novel drugs are other factors impelling the regional market growth. On the other hand, the Asia Pacific market for human growth hormone is estimated to value for the highest growth in the forecast period owing to the focus of major market players towards gaining a major market share in potential countries of this region.

COVID-19 Impact

The COVID-19 pandemic is anticipated to positively impact the global human growth hormone market owing to the heightened product innovations in this unprecedented situation. The key players of the market are increasingly investing in technological advancements and R&D activities to introduce novel drugs. This has helped the overall market to grow exponentially during the coronavirus chaos. Also, the market is expected to witness a tremendous growth post-COVID-19 pandemic estimated period.

KEY VENDOR TAKEAWAY

The leading players of the global human growth hormone market include Ipsen, Ferring B.V., Novartis AG, Genetech, Inc., Merck KGaA, Sandoz International GmbH, Eli Lily and Company, Pfizer, Inc., Novo Nordisk A/S, Teva Pharmaceutical Limited, and AnkeBio Limited. These players are implementing several strategies such as mergers, acquisitions, and partnerships to hold a strong position in the global industry.

For instance, in February 2018, Ispen and Arix Bioscience entered into a strategic agreement with an aim to develop innovatively and commercialize human growth hormone deficiency therapies.

The market size and forecast for each segment and sub-segments has been considered as below:

Historical Year - 2015 to2018

Base Year - 2019

Estimated Year - 2020

Projected Year - 2026

TARGET AUDIENCE

Traders, Distributors, and Suppliers

Manufacturers

Government and Regional Agencies

Research Organizations

Consultants

Distributors

Scope of the Report

The scope of this report covers the market by its major segments, which include as follows:

HUMAN GROWTH HORMONE MARKET KEY PLAYERS

Ipsen

Ferring B.V.

Novartis AG

Genetech, Inc.

Merck KGaA

Sandoz International GmbH

Eli Lily and Company

Pfizer, Inc.

Novo Nordisk A/S

Teva Pharmaceutical Limited

AnkeBio Limited

HUMAN GROWTH HORMONE MARKET, BY APPLICATION

Turner Syndrome

Growth Hormone Deficiency

Pediatric Growth Hormone Deficiency

Adult Growth Hormone Deficiency

Idiopathic Short Stature

Small for Gestational Age

Prader-Willi Syndrome

HUMAN GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION

Subcutaneous

Oral

Intramuscular

Intravenous

HUMAN GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL

Online Pharmacy

Retail Pharmacy

Hospital Pharmacy

Specialty Pharmacy

HUMAN GROWTH HORMONE MARKET, BY REGION

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Singapore

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Rest of LATAM

The Middle East and Africa

Saudi Arabia

United Arab Emirates

Rest of MEA

TABLE OF CONTENT

1. HUMAN GROWTH HORMONE MARKET OVERVIEW

  • 1.1. Study Scope
  • 1.2. Assumption and Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Application
    • 2.1.2. Market Snippet by Route of Administration
    • 2.1.3. Market Snippet by Distribution Channel
    • 2.1.4. Market Snippet by Region
  • 2.2. Competitive Insights

3. HUMAN GROWTH HORMONE KEY MARKET TRENDS

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. HUMAN GROWTH HORMONE INDUSTRY STUDY

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. HUMAN GROWTH HORMONE MARKET LANDSCAPE

  • 5.1. Market Share Analysis
  • 5.2. Key Innovators
  • 5.3. Breakdown Data, by Key manufacturer
    • 5.3.1. Established Player Analysis
    • 5.3.2. Emerging Player Analysis

6. HUMAN GROWTH HORMONE MARKET - BY APPLICATION

  • 6.1. Overview
    • 6.1.1. Segment Share Analysis, By Application, 2019 & 2026 (%)
  • 6.2. Turner Syndrome
    • 6.2.1. Overview
    • 6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.3. Growth Hormone Deficiency
    • 6.3.1. Overview
    • 6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 6.3.3. Paediatric Growth Hormone Deficiency
      • 6.3.3.1. Overview
      • 6.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 6.3.4. Adult Growth Hormone Deficiency
      • 6.3.4.1. Overview
      • 6.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.4. Idiopathic Short Stature
    • 6.4.1. Overview
    • 6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.5. Small for Gestational Age
    • 6.5.1. Overview
    • 6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.6. Prader-Willi Syndrome
    • 6.6.1. Overview
    • 6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

7. HUMAN GROWTH HORMONE MARKET - BY ROUTE OF ADMINISTRATION

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Application, 2019 & 2026 (%)
  • 7.2. Subcutaneous
    • 7.2.1. Overview
    • 7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.3. Oral
    • 7.3.1. Overview
    • 7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.4. Intramuscular
    • 7.4.1. Overview
    • 7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.5. Intravenous
    • 7.5.1. Overview
    • 7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

8. HUMAN GROWTH HORMONE MARKET - BY DISTRIBUTION CHANNEL

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2019 & 2026 (%)
  • 8.2. Online Pharmacy
    • 8.2.1. Overview
    • 8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.3. Retail Pharmacy
    • 8.3.1. Overview
    • 8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.4. Hospital Pharmacy
    • 8.4.1. Overview
    • 8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.5. Specialty Pharmacy
    • 8.5.1. Overview
    • 8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9. HUMAN GROWTH HORMONE MARKET- BY GEOGRAPHY

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Route of Administration, 2015 - 2026 (US$ Million)
    • 9.2.6. North America Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)
    • 9.2.7. The U.S.
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.2.8. Canada
      • 9.2.8.1. Overview
      • 9.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Route of Administration, 2015 - 2026 (US$ Million)
    • 9.3.6. Europe Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)
    • 9.3.7. Germany
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.3.8. Italy
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.3.9. United Kingdom
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.3.10. France
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.3.11. Rest of Europe
      • 9.3.11.1. Overview
      • 9.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2015 - 2026 (US$ Million)
    • 9.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)
    • 9.4.7. India
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.4.8. China
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.4.9. Japan
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.4.10. South Korea
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.4.11. Rest of APAC
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.5.4. Asia Pacific Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Route of Administration, 2015 - 2026 (US$ Million)
    • 9.5.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)
    • 9.5.7. Brazil
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.5.8. Mexico
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.5.9. Argentina
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.6. The Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Key Manufacturers in the Middle East and Africa
    • 9.6.3. The Middle East and Africa Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 9.6.4. The Middle East and Africa Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
    • 9.6.5. The Middle East and Africa Market Size and Forecast, By Route of Administration, 2015 - 2026 (US$ Million)
    • 9.6.6. The Middle East and Africa Market Size and Forecast, By Distribution Channel, 2015 - 2026 (US$ Million)
    • 9.6.7. Saudi Arabia
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 9.6.8. United Arab Emirates
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

10. KEY VENDOR ANALYSIS

  • 10.1. Ipsen
    • 10.1.1. Company Snapshot
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Strategic Initiatives
  • 10.2. Ferring B.V.
  • 10.3. Novartis AG
  • 10.4. Genetech, Inc.
  • 10.5. Merck KGaA
  • 10.6. Sandoz International GmbH
  • 10.7. Eli Lily and Company
  • 10.8. Pfizer, Inc.
  • 10.9. Novo Nordisk A/S
  • 10.10. Teva Pharmaceutical Limited
  • 10.11. AnkeBio Limited

11. 360 DEGREE ANALYSTVIEW

12. APPENDIX

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.